Sequence Similarity Clusters for the Entities in PDB 1EO8

Entity #1 | Chains: A
HEMAGGLUTININ (HA1 CHAIN) protein, length: 328 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 13 1510
95 % 22 50 275 Flexibility: Low
Max RMSD: 2.2, Avg RMSD: 0.5
PDBFlex
90 % 22 50 287
70 % 41 83 203
50 % 52 94 215
40 % 179 359 18
30 % 182 367 31
Entity #2 | Chains: B
HEMAGGLUTININ (HA2 CHAIN) protein, length: 175 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 3 19 873
95 % 41 80 207 Flexibility: Low
Max RMSD: 5.0, Avg RMSD: 0.9
PDBFlex
90 % 41 80 215
70 % 89 164 80
50 % 178 360 10
40 % 183 371 16
30 % 187 377 30
Entity #3 | Chains: L
ANTIBODY (LIGHT CHAIN) protein, length: 210 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 64695
95 % 1 1 52563
90 % 59 154 142
70 % 1649 2700 1
50 % 3370 5489 1
40 % 3827 6196 1
30 % 4706 7674 1
Entity #4 | Chains: H
ANTIBODY (HEAVY CHAIN) protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 61910
95 % 1 1 50528
90 % 1 1 47889
70 % 1629 2662 2
50 % 3371 5489 1
40 % 3828 6196 1
30 % 4707 7674 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 6CNW 1 A humanized antibody SD84h 37965
2 5IVN 1 A BC2-nanobody 30538
3 5E7B 1 A nanobody nano-L06 9838
4 2P45 2 B ANTIBODY CAB-RN05 9838
5 2X1Q 1 A, B GELSOLIN NANOBODY 9844
6 5U64 1 B VHH-28 9838
7 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
8 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
9 4B41 1 A, B ANTIBODY G7 9844
10 4NZU 1 L 13PL heavy chain Fab 9606
11 4NZU 2 H 13PL light chain Fab 9606
12 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
13 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
14 5IMM 1 B Nanobody 9835
15 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
16 5NLU 1 A single domain llama antibody Nb36 9844
17 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
18 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
19 1MEX 1 L Fab 29G12 light chain 10090
20 1MEX 2 H Fab 29G12 heavy chain 10090
21 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
22 5IMK 1 B Nanobody 9835
23 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
24 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
25 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
26 4BUH 1 A, B CLONE M0418 SCFV 9606
27 4B50 1 A 2H10 LLAMA VHH 9844
28 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
29 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
30 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
31 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
32 6DBA 1 A, B nanobody VHH R303 9838
33 5YD4 1 A, C, E, G scFv 4B08 10090
34 5YD3 1 A, C, E, G scFv 4B08 10090
35 2XT1 2 B CAMELID VHH 9 30538
36 5UD9 1 H Fab heavy chain 9606
37 5UD9 2 L Light chain 9606
38 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
39 4P48 1 A Antibody scFv 180 9031
40 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
41 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
42 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
43 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
44 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
45 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
46 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
47 5J1S 3 C VHH domain BS-2 30538
48 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
49 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
50 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
51 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
52 6MEE 2 B, D antibody HEPC74 Light Chain 9606
53 6BJZ 1 H 5c8 Fab Heavy chain 9606
54 6BJZ 2 L 5c8 Fab Light chain 9606
55 5J1T 3 C VHH domain BS-2 30538
56 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
57 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
58 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
59 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
60 4XCF 1 L 4E10 Fab light chain 9606
61 4XCF 2 H 4E10 Fab heavy chain 9606
62 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
63 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
64 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
65 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
66 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
67 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
68 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
69 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
70 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
71 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
72 5X08 1 H Fab 4E10 Heavy chain 9606
73 5X08 2 L Fab 4E10 Light chain 9606
74 6MEG 1 H antibody HEPC46 Heavy Chain 9606
75 6MEG 2 L antibody HEPC46 Light Chain 9606
76 2X1O 1 A, B GELSOLIN NANOBODY 9844
77 4QGY 1 A, B nanobody n25, VH domain 9844
78 5C2B 1 H scFv 3B4 heavy chain 9606
79 4XAW 1 L 4E10 Fab light chain 9606
80 4XAW 2 H 4E10 Fab heavy chain 9606
81 5VNV 1 A Nb.b201 32630
82 4P49 1 A Antibody scFv B8 9031
83 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
84 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
85 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
86 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
87 5DXW 1 A PD-L1 nanobody 10090
88 5UCB 1 H Fab Heavy Chain 9606
89 5UCB 2 L Fab Light Chain 9606
90 2VXV 1 H HUMAN IGG ABT-325 9606
91 2VXV 2 L HUMAN IGG ABT-325 9606
92 4N9O 2 B Nanobody Nb484 Nb484 9844
93 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
94 4GXV 1 H, I Antibody 1F1, heavy chain 9606
95 4GXV 2 L, M Antibody 1F1, light chain 9606
96 2VXT 1 H MURINE IGG 125-2H 10090
97 2VXT 3 L MURINE IGG 125-2H 10090
98 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
99 1T2J 1 A M12-Variable Heavy domain 9606
100 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
101 6DBF 2 B InlB specific VHH R303 9838
102 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
103 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
104 6DBG 2 C, D VHH R303 9838
105 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
106 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
107 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
108 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
109 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
110 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
111 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
112 5W24 1 L 5C4 Fab Light Chain 10090
113 5W24 2 H 5C4 Fab Heavy Chain 10090
114 4HPY 1 H CH59 Fab heavy chain 9606
115 4HPY 2 L CH59 Fab light chain 9606
116 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
117 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
118 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
119 5VM6 1 A single domain camelid nanobody VHH T10 9844
120 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
121 4JG1 1 L Fab light chain 9606
122 4JG1 2 H Fab heavy chain 9606
123 6E65 1 L TB31F Fab light chain 9606
124 6E65 2 H TB31F Fab heavy chain 9606
125 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
126 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
127 4KML 2 B Nanobody 9844
128 5VF2 1 A scFv 2D10 10090
129 5I8C 1 A VRC34.01 Fab heavy chain 9606
130 5I8C 2 B VRC34.01 Fab light chain 9606
131 4O5L 1 L Fab F045-092 light chain 9606
132 4O5L 2 H Fab F045-092 heavy chain 9606
133 5MYX 1 A, C Fab c#24 light chain 10090
134 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
135 4Z9K 2 B VHH2(F5) antibody 30538
136 3IFL 1 L 12A11 FAB antibody light chain 10090
137 3IFL 2 H 12A11 FAB antibody heavy chain 10090
138 5WK2 1 L M116 LIGHT CHAIN 9606
139 5WK2 2 H M116 HEAVY CHAIN FD 9606
140 3PP4 1 H GA101 Fab heavy chain 10090
141 3PP4 2 L GA101 Fab light chain 10090
142 3KDM 1 A, L Immunoglobulin light chain 9606
143 3KDM 2 B, H Immunoglobulin heavy chain 9606
144 5NIV 1 A Light chain of 5D3 Fab 10090
145 5NIV 2 B Heavy chain of 5D3 Fab 10090
146 5N4J 1 L LIGHT CHAIN 9606
147 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
148 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
149 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
150 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
151 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
152 5X4G 1 A 6H8 Fab heavy chain 10090
153 5X4G 2 B 6H8 Fab light chain 10090
154 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
155 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
156 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
157 4PTU 1 A Antibody pn132p2C05, light chain 9606
158 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
159 4TPR 1 L If kappa light chain 10090
160 4TPR 2 H Fab heavy chain 10090
161 5LMW 1 A Nanobody 9844
162 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
163 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
164 3IFN 1 H 12A11 FAB antibody heavy chain 10090
165 3IFN 2 L 12A11 FAB antibody light chain 10090
166 5U3P 1 H DH511.4 Fab Heavy Chain 9606
167 5U3P 2 L DH511.4 Fab Light Chain 9606
168 6BLA 1 H AMM01 Fab Heavy chain 9606
169 6BLA 2 L AMM01 Fab Light chain 9606
170 5NM0 1 A, B, C, D Nb36 9844
171 4TOY 1 H 35O22 Fab Heavy chain 9606
172 4TOY 2 L 35O22 Fab Light chain 9606
173 6H6Y 2 E, F, G, H Nanobody (VHH) Nano-7 30538
174 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
175 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
176 3NPS 2 B S4 FAB HEAVY CHAIN 9606
177 3NPS 3 C S4 FAB LIGHT CHAIN 9606
178 5I4F 1 A scFv 2D10 10090
179 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
180 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
181 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
182 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
183 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
184 5WN9 1 H scFv 2D10 9606
185 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
186 4XC3 1 L 4E10 Fab light chain 9606
187 4XC3 2 H 4E10 Fab heavy chain 9606
188 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
189 4PPT 1 A Engineered single domain VHH antibody 9844
190 3R0M 1 A, B Llama VHH A12 9844
191 4M5Y 1 H, I Fab 5J8 heavy chain 9606
192 4M5Y 2 L, M Fab 5J8 light chain 9606
193 4TQE 1 L If kappa light chain 10090
194 4TQE 2 H Fab heavy chain 10090
195 3ZKQ 2 D XA4813 9844
196 5YY4 1 A scFv 4B08 10090
197 4I13 2 B Protein ca1697 (nanobody) 9844
198 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
199 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
200 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
201 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
202 5C2U 1 B Nanobody Nanobody 9838
203 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
204 5VSI 2 L CH1/Ckappa Fab light chain 9606
205 1XFP 1 A heavy chain antibody VHH domain 9838
206 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
207 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
208 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
209 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
210 5JXA 1 H VRC03 Heavy chain 9606
211 5JXA 2 L VRC03 Light chain 9606
212 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
213 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
214 4POY 1 A VHH-metal 9844
215 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
216 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
217 5NLW 1 A nanobody Nb36 9844
218 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
219 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
220 3NTC 1 L Fab light chain 10090
221 3NTC 2 H Fab heavy chain 10090
222 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
223 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
224 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
225 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
226 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
227 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
228 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
229 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
230 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
231 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
232 6BE3 1 H Fab (F598) Heavy Chain 9606
233 6BE3 2 L Fab (F598) Light Chain 9606
234 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
235 3G9A 2 B Minimizer 9838
236 4NWU 1 H APE1551 Ab Fab heavy chain 9606
237 4NWU 2 L APE1551 Ab Fab light chain 9606
238 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
239 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
240 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
241 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
242 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
243 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
244 5EWI 1 H VRC38.01 Heavy Chain 9606
245 5EWI 2 L VRC38.01 Light Chain 9606
246 5E2W 1 L AT8 LIGHT CHAIN 10090
247 5E2W 2 H AT8 HEAVY CHAIN 10090
248 5MYK 1 A Fab c#17 light chain 10090
249 5MYK 2 B Fab c#17 heavy chain 10090
250 4NZR 1 H PGT135 heavy chain Fab 9606
251 4NZR 2 L PGT135 light chain Fab 9606
252 5MYO 1 A, C Fab c#6 light chain 10090
253 5MYO 2 B, D Fab c#6 heavy chain 10090
254 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
255 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
256 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
257 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
258 5UEL 1 H 354NC102 Fab Heavy Chain 9606
259 5UEL 2 L 354NC102 Fab Light Chain 9606
260 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
261 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
262 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
263 2P43 2 B ANTIBODY CAB-RN05 9838
264 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
265 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
266 5E2V 1 L AT8 LIGHT CHAIN 10090
267 5E2V 2 H AT8 HEAVY CHAIN 10090
268 4KRN 1 A Nanobody/VHH domain EgA1 9844
269 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
270 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
271 4GFT 2 B Nanobody 9844
272 4TVS 2 a, b VHH Domain BS-1 30538
273 4W6Y 2 B Nanobody NbFedF9 9844
274 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
275 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
276 6EZW 1 B VHH antibody BCD090-M2 9844
277 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
278 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
279 5JUE 1 L light chain of UIC2 Fab 10090
280 5JUE 2 H heavy chain of UIC2 Fab 10090
281 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
282 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
283 1UAC 2 H Ig VH,anti-lysozyme 10090
284 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
285 5JR1 1 H 10E8 heavy chain 9606
286 5JR1 2 L 10E8 mature light chain 9606
287 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
288 6CA7 1 L PCT64_13C light chain 9606
289 6CA7 2 H PCT64_13C heavy chain 9606
290 5VF6 1 A single chain variable fragment 9031
291 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
292 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
293 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
294 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
295 5OB5 2 H fAb Heavy chain 9606
296 5OB5 3 L fAb Light chain 9606
297 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
298 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
299 5I66 1 A 8B6 antibody, heavy chain 10090
300 5I66 2 B 8B6 antibody, light chain 10090
301 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
302 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
303 6BZY 1 H 22D11 Heavy Chain 10090
304 6BZY 2 L 22D11 Light Chain 10090
305 3QQ9 1 C, L 101F LIGHT CHAIN 10090
306 3QQ9 2 D, H 101F HEAVY CHAIN 10090
307 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
308 5TKK 3 L mouse antibody vFP5.01 light chain 10090
309 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
310 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
311 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
312 5W6C 1 H UCA Fab heavy chain 9606
313 5W6C 2 L UCA Fab light chain 9606
314 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
315 5I1K 1 L FAB LIGHT CHAIN 9606
316 5I1K 2 H FAB HEAVY CHAIN 9606
317 3OZ9 1 L Fab NC-1 kappa light chain 10090
318 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
319 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
320 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
321 5V7U 1 L CBTAU-22.1 Fab light chain 9606
322 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
323 5UEA 1 A, H Fab Heavy Chain 9606
324 5UEA 3 B, L Fab Light Chain 9606
325 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
326 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
327 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
328 3G5Y 1 A 175 light chain 10090
329 3G5Y 2 B 175 heavy chain 10090
330 5O02 2 C Nanobody (VHH) Nano-4 30538
331 5NMV 1 L Fab light chain 10088
332 5NMV 2 H Fab heavy chain 10088
333 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
334 4N8C 2 L, M Light chain of monoclonal antibody 10090
335 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
336 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
337 4HGW 1 A Antibody Fab fragment, light chain 10090
338 4HGW 2 B Antibody Fab fragment, heavy chain 10090
339 1NLB 1 L antibody 19D9D6 light chain 10090
340 1NLB 2 H antibody 19D9D6 heavy chain 10090
341 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
342 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
343 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
344 3VFG 1 L 3F8 Light Chain 10090
345 3VFG 2 H 3F8 Heavy Chain 10090
346 4X7F 2 C, D Nano-25 Nanobody 30538
347 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
348 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
349 3QRG 1 L Fab light chain 9606
350 3QRG 2 H Fab heavy chain Fd fragment 9606
351 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
352 5M6A 1 A, B, C, D Bence-Jones light chain 9606
353 4LLY 2 B, D light chain Clambda 9606
354 4LGR 2 B Camelid nanobody (VHH3) 30538
355 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
356 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
357 5EZI 1 H Fab c12 heavy chain 9606
358 5EZI 2 L Fab c12 Light chain 9606
359 4K23 1 H anti-uPAR antibody, heavy chain 10090
360 4K23 2 L anti-uPAR antibody, light chain 10090
361 5J57 2 B VHH single chain antibody V5E1 30538
362 3NCJ 1 L Fab15 Mut8 light chain 9606
363 3NCJ 2 H Fab15 Mut8 heavy chain 9606
364 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
365 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
366 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
367 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
368 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
369 5W05 1 L M59 FAB LIGHT CHAIN 10090
370 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
371 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
372 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
373 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
374 5OMM 2 C Nanobody (VHH) Nano-14 30538
375 5E03 1 A mouse CTLA-4 nanobody 10090
376 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
377 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
378 4M61 1 A, C Fab A52 light chain 10090
379 4M61 2 B, D Fab A52 heavy chain 10090
380 5YE3 1 B 2A7D9 VH CH1 chain 10090
381 5YE3 2 A 2A7D9 L chain 10090
382 5LZ0 1 A, B PorM nanobody 9844
383 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
384 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
385 1UM5 1 L Antibody 21H3 L chain 10090
386 1UM5 2 H Antibody 21H3 H chain 10090
387 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
388 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
389 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
390 4NWT 1 L APE1531 Ab Fab light chain 9606
391 4NWT 2 H APE1531 Ab Fab heavy chain 9606
392 6DBE 1 A, B nanobody VHH R303 9844
393 3WHX 1 A mAb Fab H fragment 10090
394 3WHX 2 B mAb Fab L fragment 10090
395 3NA9 1 L Fab15 light chain 9606
396 3NA9 2 H Fab15 heavy chain 9606
397 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
398 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
399 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
400 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
401 4LRI 1 A, B MSL-109 Light Chain 9606
402 4LRI 2 C, P MSL-109 Heavy Chain 9606
403 2XXC 1 B CAMELID VHH 9 30538
404 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
405 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
406 4JN2 1 A, L anti dabigatran Fab 10090
407 4JN2 2 B, H anti dabigatran Fab 10090
408 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
409 4XBE 2 H 4E10 Fab heavy chain 9606
410 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
411 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
412 6BE2 1 H Fab (F598) Heavy Chain 9606
413 6BE2 2 L Fab (F598) Light Chain 9606
414 3QYC 1 A, B VH domain of IgG molecule 9606
415 4JFZ 1 L Fab light chain 9606
416 4JFZ 2 H Fab heavy chain 9606
417 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
418 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
419 5VAK 2 B Nb914 Nanobody 9844
420 3WIF 1 A mAb Fab H fragment 10090
421 3WIF 2 B mAb Fab L fragment 10090
422 5U6A 1 A Light Chain 9606
423 5U6A 2 B Heavy Chain 9606
424 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
425 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
426 3MBX 1 L X836 LIGHT CHAIN 10090
427 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
428 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
429 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
430 2XXM 2 B CAMELID VHH 9 30538
431 6APC 1 H Epididymis luminal protein 214 9606
432 6APC 2 L IGL@ protein 9606
433 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
434 4HHA 1 A Fab KE5 Fab fragment KE5 9606
435 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
436 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
437 4RGO 2 H 14G8 heavy chain Fab 10090
438 4RGO 3 L 14G8 light chain Fab 10090
439 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
440 5GRY 1 A, G diabody 9606
441 5UEK 2 H Fab 12E Heavy Chain 9606
442 5UEK 3 L Fab 12E Light Chain 9606
443 3NAA 1 L Fab15 Mut5 light chain 9606
444 3NAA 2 H Fab15 Mut5 heavy chain 9606
445 6DBD 1 A, B, C, D nanobody VHH R326 9844
446 1Q0X 1 L Fab 9B1, light chain 10090
447 1Q0X 2 H Fab 9B1, heavy chain 10090
448 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
449 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
450 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
451 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
452 5JDS 1 B Nanobody 9835
453 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
454 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
455 5IK3 2 B, D 1E03 Fab fragment light chain 9606
456 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
457 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
458 5XLI 1 a, b FabL 10090
459 5XLI 2 c, d FabH 10090
460 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
461 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
462 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
463 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
464 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
465 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
466 4WUK 1 H CH65 heavy chain 9606
467 4WUK 2 L CH65 light chain 9606
468 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
469 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
470 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
471 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
472 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
473 5JOP 1 D, L Fab 14.22 light chain 10090
474 5JOP 2 E, H Fab14.22 heavy chain 10090
475 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
476 4HPO 1 H CH58 Fab heavy chain 9606
477 4HPO 2 L CH58 Fab light chain 9606
478 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
479 5UKN 2 L DH522UCA Fab fragment light chain 9544
480 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
481 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
482 5L21 2 B VHH-C2 30538
483 5IT2 1 H heavy chain 9606
484 5IT2 2 L light chain 9606
485 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
486 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
487 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
488 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
489 5FWO 1 A NANOBODY 9844
490 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
491 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
492 5MO3 3 L Fab of monoclonal antibody, light chain 10090
493 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
494 5GZ0 1 A, C FM329 light chain 1383439
495 5GZ0 2 B, D FM329 heavy chain 1383439
496 6DW2 1 A 6078 Fab light chain 9606
497 6DW2 2 B 6078 Fab heavy chain 9606
498 3B9V 1 A, B, C, D heavy chain variable domain 9606
499 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
500 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
501 6BQB 1 L MGG4 Fab light chain 9606
502 6BQB 2 H MGG4 Fab heavy chain 9606
503 4PUB 1 H DX-2930 HEAVY CHAIN 9606
504 4PUB 2 L DX-2930 LIGHT CHAIN 9606
505 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
506 6B14 2 L Light chain of Fab BL3-6S97N 10090
507 5N88 1 A, H VH59 antibody 9606
508 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
509 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
510 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
511 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
512 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
513 5GS3 1 A, H diabody protein 9606
514 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
515 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
516 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
517 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
518 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
519 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
520 5VKD 2 H Fab Heavy Chain 9606
521 5VKD 3 L Fab light chain 9606
522 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
523 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
524 5XHG 1 A, C polypeptide(L) 10090
525 5XHG 2 B, D polypeptide(H) 10090
526 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
527 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
528 3UYR 1 H antibody Fab heavy chain 10090
529 3UYR 2 L antibody Fab light chain 10090
530 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
531 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
532 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
533 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
534 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
535 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
536 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
537 3OAZ 2 K, L Fab 2G12, light chain 9606
538 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
539 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
540 1ZAN 1 L Fab AD11 Light Chain 10116
541 1ZAN 2 H Fab AD11 Heavy Chain 10116
542 6CJK 1 A, C Immunoglobulin Fab light chain 9986
543 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
544 4N0Y 1 H IGH526 Heavy Chain 9606
545 4N0Y 2 L IGH526 Light Chain 9606
546 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
547 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
548 5MTH 1 A, H antibody Fab heavy chain 10090
549 5MTH 2 B, L antibody Fab light chain 10090
550 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
551 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
552 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
553 1RZF 1 L Fab E51 light chain 9606
554 1RZF 2 H Fab E51 heavy chain 9606
555 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
556 4KTE 2 L GE148 Light Chain Fab 9544
557 5I8O 1 H HMM5 antibody heavy chain 9606
558 5I8O 2 L HMM5 antibody light chain 9606
559 4OUO 1 A anti Bla g 1 scFv 9031
560 4JG0 1 L Fab light chain 9606
561 4JG0 2 H Fab heavy chain 9606
562 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
563 4YGV 2 B, L aDabi-Fab2a light chain 9606
564 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
565 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
566 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
567 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
568 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
569 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
570 3EO0 1 A, C GC-1008 Fab Light Chain 10090
571 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
572 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
573 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
574 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
575 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
576 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
577 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
578 4POU 2 B VHH Antibody 9844
579 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
580 4FQI 3 H antibody CR9114 heavy chain Fab 9606
581 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
582 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
583 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
584 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
585 4JHA 2 L D25 light chain 9606
586 6B9Z 1 A Trastuzumab Fab light chain 10090
587 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
588 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
589 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
590 4PTT 1 A Antibody pn132p2C05, light chain 9606
591 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
592 6H70 2 C, D Nanobody (VHH) Nano-62 30538
593 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
594 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
595 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
596 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
597 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
598 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
599 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
600 2P42 2 B, D ANTIBODY CAB-RN05 9838
601 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
602 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
603 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
604 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
605 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
606 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
607 4DGV 1 H HCV1 Heavy Chain Fab 9606
608 4DGV 2 L HCV1 Light Chain 9606
609 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
610 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
611 5TH2 1 A, C cetuximab Fab, light chain 10090
612 5TH2 2 B, D cetuximab Fab, heavy chain 10090
613 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
614 5I8K 1 L HHH1 Fab Light chain 9606
615 5I8K 2 H HHH1 Fab Heavy chain 9606
616 4QLR 1 A, B Llama nanobody n02 VH domain 9844
617 5J56 2 B VHH single chain antibody V1C7 30538
618 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
619 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
620 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
621 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
622 1YNL 1 L Ig gamma light chain 10090
623 1YNL 2 H Ig gamma heavy chain 10090
624 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
625 5EPM 2 B, F Antibody Fab fragment light chain 10090
626 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
627 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
628 3UMT 1 A scFv heavy chain and light chain 10090
629 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
630 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
631 4NUJ 1 A PGT152 light chain 9606
632 4NUJ 2 B PGT152 heavy chain 9606
633 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
634 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
635 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
636 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
637 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
638 3U2S 2 B, L PG9 light chain 9606
639 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
640 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
641 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
642 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
643 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
644 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
645 4NUG 1 L PGT151 light chain 9606
646 4NUG 2 H PGT151 heavy chain 9606
647 3IU4 1 H chP3 Fab heavy chain 10090
648 3IU4 2 L chP3 Fab light chain 10090
649 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
650 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
651 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
652 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
653 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
654 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
655 1P7K 1 A, L antibody light chain FAB 10090
656 1P7K 2 B, H antibody heavy chain FAB 10090
657 4NBX 2 B A20.1 VHH 9844
658 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
659 3RVV 2 C 4C1 - light chain 10090
660 3RVV 3 D 4C1 - heavy chain 10090
661 4HEP 2 G vHH17 domain 9844
662 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
663 3P0Y 2 H Fab DL11 heavy chain 9606
664 3P0Y 3 L Fab DL11 light chain 9606
665 4NPY 1 A, L germline PGT121 light chain Fab 9606
666 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
667 6ANA 2 H LL2 Fab Heavy Chain 10090
668 6ANA 3 L LL2 Fab Light Chain 10090
669 5IBU 1 B, L 6652 Light Chain 9606
670 5IBU 2 G, H 6652 Heavy Chain 9606
671 5VPL 2 C 4C1 - LIGHT CHAIN 10090
672 5VPL 3 D 4C1 - HEAVY CHAIN 10090
673 6AOD 1 A FXIa Antibody FAB Light Chain 9606
674 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
675 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
676 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
677 2YPV 2 H FAB 12C1 10090
678 2YPV 3 L FAB 12C1 10090
679 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
680 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
681 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
682 4JY5 1 L PGT122 light chain Fab 9606
683 4JY5 2 H PGT122 heavy chain Fab 9606
684 6ELE 1 A, H fAB heavy chain 9606
685 6ELE 2 B, L fAB light chain 9606
686 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
687 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
688 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
689 6B5R 1 H CIS42 Fab Heavy chain 9606
690 6B5R 2 L CIS42 Fab Light chain 9606
691 5IML 2 B Nanobody 9835
692 3NAC 1 L Fab15 Mut7 light chain 9606
693 3NAC 2 H Fab15 Mut7 heavy chain 9606
694 3A6C 2 H IG VH, anti-lysozyme 10090
695 2DQD 2 H Ig VH,anti-lysozyme 10090
696 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
697 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
698 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
699 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
700 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
701 1Q72 1 L Fab M82G2, Light chain 10090
702 1Q72 2 H Fab M82G2, Heavy chain 10090
703 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
704 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
705 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
706 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
707 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
708 4YHO 1 H aDabi-Fab3 heavy chain 9606
709 4YHO 2 L aDabi-Fab3 light chain 9606
710 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
711 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
712 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
713 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
714 4DGY 1 H HCV1 Heavy Chain Fab 9606
715 4DGY 2 L HCV1 Light Chain 9606
716 3A67 2 H IG VH, anti-lysozyme 10090
717 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
718 5EN2 1 A GD01 heavy chain 10090
719 5EN2 2 B GD01 light chain 10090
720 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
721 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
722 1J1X 2 H Ig VH,anti-lysozyme 10090
723 5M2J 2 D Anti-(ED-B) scFV 9606
724 3MXW 2 L 5E1 light chain 9606
725 3MXW 3 H 5E1 heavy chain 9606
726 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
727 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
728 2DQC 2 H Ig VH,anti-lysozyme 10090
729 1J1O 2 H Ig VH,anti-lysozyme 10090
730 3EO9 1 L Efalizumab Fab fragment, light chain 9606
731 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
732 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
733 4M62 2 H, I GEP2 FV heavy chain 9606
734 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
735 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
736 5IVO 1 A BC2-nanobody 30538
737 1J1P 2 H Ig VH,anti-lysozyme 10090
738 6N35 1 K, L Fab 2G12 light chain 9606
739 6N35 2 H, M Fab 2G12 heavy chain 9606
740 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
741 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
742 4NBZ 2 B, D A26.8 VHH 9844
743 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
744 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
745 5WUV 1 L light chain 9606
746 5WUV 2 H heavy chain 9606
747 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
748 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
749 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
750 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
751 5AYU 2 H Ig VH,anti-lysozyme 10090
752 4JM4 1 H PGT 135 Heavy Chain Fab 9606
753 4JM4 2 L PGT 135 Light Chain Fab 9606
754 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
755 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
756 3A6B 2 H IG VH, anti-lysozyme 10090
757 2DQJ 2 H Ig VH,anti-lysozyme 10090
758 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
759 5YE4 2 B, D 1A9D7 L chain 10090
760 5F21 2 B nanobody MU375 9844
761 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
762 6B0G 1 C 1245 Antibody, Light Chain 9606
763 6B0G 2 D 1245 Antibody, Heavy Chain 9606
764 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
765 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
766 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
767 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
768 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
769 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
770 6D0X 1 A 2140 Antibody, heavy chain 9606
771 6D0X 2 B 1210 Antibody, light chain 9606
772 2P44 2 B ANTIBODY CAB-RN05 9838
773 6BE4 1 H Fab (F598) Heavy Chain 9606
774 6BE4 2 L Fab(F598) Light Chain 9606
775 5TPP 1 L DH270.5 Fab heavy chain 9606
776 5TPP 2 H DH270.5 Fab light chain 9606
777 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
778 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
779 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
780 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
781 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
782 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
783 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
784 5TP3 1 A, B F-VHH-4 9844
785 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
786 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
787 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
788 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
789 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
790 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
791 5TL5 1 L M2177 LIGHT CHAIN 10090
792 5TL5 2 H M2177 HEAVY CHAIN 10090
793 2FX7 1 L Fab 4E10 Light Chain 9606
794 2FX7 2 H Fab 4E10 Heavy Chain 9606
795 5Y9K 1 L belimumab light chain 9606
796 5Y9K 2 H belimumab heavy chain 9606
797 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
798 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
799 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
800 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
801 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
802 4LHJ 2 B Camelid antibody 30538
803 3WFH 1 A mAb Fab H fragment 10090
804 3WFH 2 B mAb Fab L fragment 10090
805 4BEL 2 D, E XA4813 9844
806 5M7Q 1 A, B Nanobody NbD2 9838
807 5H8D 1 A VHH nanobody 9844
808 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
809 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
810 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
811 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
812 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
813 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
814 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
815 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
816 3DUR 2 B, D Ig-like protein 10090
817 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
818 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
819 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
820 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
821 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
822 5HI4 3 D, L CAT-2000 FAB light chain 9606
823 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
824 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
825 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
826 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
827 3RVW 2 C 4C1 - light chain 10090
828 3RVW 3 D 4C1 - heavy chain 10090
829 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
830 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
831 5XKU 2 B HNIgGA6 light chain 9606
832 5XKU 3 C HNIgGA6 heavy chain 9606
833 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
834 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
835 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
836 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
837 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
838 5HI5 3 D, L CAT-2000 light chain 9606
839 5JO5 1 A, C, E, H 10E8 gHV 9606
840 5JO5 2 B, D, F, L 10E8 gLV 9606
841 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
842 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
843 2XV6 2 B, D CAMELID VHH 9 30538
844 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
845 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
846 5CCK 2 L Antibody 3BC315 Fab light chain 9606
847 5VM0 1 A, B Camelid Nanobody VHH T9 9844
848 5I76 1 A, C FM318_light_chain 1383439
849 5I76 2 B, D FM318_heavy_cahin 1383439
850 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
851 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
852 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
853 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
854 5I18 1 L FAB LIGHT CHAIN 9606
855 5I18 2 H FAB HEAVY CHAIN 9606
856 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
857 4JN1 2 L anti-dabigatran Fab1, light chain 10090
858 4ZG1 1 A, B, C, D, E, F NB17 9844
859 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
860 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
861 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
862 4G5Z 2 L canakinumab antibody fragment light chain 9606
863 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
864 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
865 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
866 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
867 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
868 2OK0 2 L Fab ED10 light chain 10090
869 2OK0 3 H Fab ED10 heavy chain 10090
870 6BAN 2 B, D, F, H Variable domain R11 Heavy chain 9606
871 3SOB 1 L antibody light chain 9606
872 3SOB 3 H antibody heavy chain 9606
873 6B5M 1 H CIS43 Fab Heavy chain 9606
874 6B5M 2 L CIS43 Fab Light chain 9606
875 4I1N 2 B Protein ca1697 (nanobody) 9844
876 5AWN 1 H Heavy chain of 3BC176 Fab 9606
877 5AWN 2 L Light chain of 3BC176 Fab 9606
878 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
879 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
880 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
881 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
882 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
883 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
884 5DR5 2 L AbD09097 Fab light chain 9606
885 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
886 2IH3 1 A FAB Heavy Chain 10090
887 2IH3 2 B FAB Light Chain 10090
888 4KQ3 1 L CNTO3186 light chain Fab 9606
889 4KQ3 2 H CNTO3186 heavy chain Fab 9606
890 6F0D 1 A, B VHH antibody BCD090-M2 9844
891 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
892 6AQ7 3 L POM6 FAB light CHAIN 10090
893 4JFX 1 A, L Fab light chain 9606
894 4JFX 2 B, H Fab heavy chain 9606
895 3SGE 1 I, L Light Chain 10090
896 3SGE 2 H, J Heavy Chain 10090
897 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
898 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
899 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
900 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
901 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
902 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
903 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
904 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
905 5FHB 1 H Antibody 100 Fab heavy chain 9606
906 5FHB 2 L Antibody 100 Fab light chain 9606
907 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
908 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
909 1JGU 1 L Antibody Light Chain 10090
910 1JGU 2 H Antibody Heavy Chain 10090
911 4I77 1 H Lebrikizumab heavy chain Fab 9606
912 4I77 2 L Lebrikizumab light chain Fab 9606
913 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
914 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
915 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
916 4O4Y 2 H 2095-2 heavy chain 9986
917 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
918 5OBF 1 H fAb Heavy chain 10090
919 5OBF 2 L fAb Light chain 10090
920 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
921 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
922 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
923 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
924 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
925 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
926 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
927 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
928 5V6M